Filana Therapeutics FLNA
NASDAQ FLNA
$0.96 +0.02 (+1.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Change in Receivables (2011)

Filana Therapeutics (FLNA) posted quarterly Change in Receivables of -$640000.0 for Q4 2011, down 221.61% quarter-over-quarter from -$199000.0 in Q3 2011.

Filana Therapeutics (FLNA) Change in Receivables (2011) Analysis & Trends

Filana Therapeutics' Change in Receivables history runs 1 years deep, the most recent figure standing at -$640000.0 for Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -53.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 117.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 31.60 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 94.29 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 37.16 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Filana Therapeutics 46.00 Mn 46.00 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 -640,000.00
Dec 31, 2011 -640,000.00
Sep 30, 2011 -199,000.00
Sep 30, 2011 -199,000.00